Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation (NYSE: XON), today announced an exclusive strategic collaboration and license ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE